BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 27755242)

  • 21. Nuclear cardiology in the context of multimodality imaging to detect cardiac toxicity from cancer therapeutics: Established and emerging methods.
    Soufer A; Liu C; Henry ML; Baldassarre LA
    J Nucl Cardiol; 2020 Aug; 27(4):1210-1224. PubMed ID: 30868378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of biomarkers in monitoring antiblastic cardiotoxicity.
    Novo G; Cadeddu C; Sucato V; Pagliaro P; Romano S; Tocchetti CG; Zito C; Longobardo L; Nodari S; Penco M
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e27-e34. PubMed ID: 27755240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-induced myocardial dysfunction - recommendations for assessment in clinical and pre-clinical studies.
    Ebrahimi A; Raichlen JS; Pointon A; Gottfridsson C; Munley J; Hockings P; Cartwright J; Buss N; Wikström J; Gan LM; Whittaker A; Khalil A; George RT; Garkaviy P; Brott D
    Expert Opin Drug Saf; 2020 Mar; 19(3):281-294. PubMed ID: 32064957
    [No Abstract]   [Full Text] [Related]  

  • 24. Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection.
    Madonna R; Cadeddu C; Deidda M; Mele D; Monte I; Novo G; Pagliaro P; Pepe A; Spallarossa P; Tocchetti CG; Zito C; Mercuro G
    Heart Fail Rev; 2015 Sep; 20(5):621-31. PubMed ID: 26168714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac Imaging: Multimodality Advances and Surveillance Strategies in Detection of Cardiotoxicity.
    Moonen M; Oury C; Lancellotti P
    Curr Oncol Rep; 2017 Aug; 19(10):63. PubMed ID: 28791609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology.
    Spallarossa P; Maurea N; Cadeddu C; Madonna R; Mele D; Monte I; Novo G; Pagliaro P; Pepe A; Tocchetti CG; Zito C; Mercuro G
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e84-e92. PubMed ID: 27755246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early diagnosis of chemotherapy-induced cardiotoxicity by cardiac MRI.
    Cau R; Bassareo P; Cherchi V; Palmisano V; Suri JS; Porcu M; Balestrieri A; Pontone G; Saba L
    Eur J Radiol; 2020 Sep; 130():109158. PubMed ID: 32652404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy-induced cardiotoxicity: detection, prevention, and management.
    Truong J; Yan AT; Cramarossa G; Chan KK
    Can J Cardiol; 2014 Aug; 30(8):869-78. PubMed ID: 25064580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging Cardiac Imaging Modalities for the Early Detection of Cardiotoxicity Due to Anticancer Therapies.
    López-Fernández T; Thavendiranathan P
    Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):487-495. PubMed ID: 28189542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnostic imaging methods of cardiac dysfunction caused by cardiotoxicity of oncological therapy].
    Lelakowska-Pieła M; Słowik A; Kozynacka A; Panek M; Konduracka E; Nessler J
    Pol Merkur Lekarski; 2016 Jan; 40(235):36-9. PubMed ID: 26891435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardio-oncology: the role of advanced echocardiography in cancer patients.
    Venneri L; Zoppellaro G; Khattar RS
    Expert Rev Cardiovasc Ther; 2018 Apr; 16(4):249-258. PubMed ID: 29457984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Routine Prophylactic Cardioprotective Therapy Should Not Be Given to All Recipients of Potentially Cardiotoxic Cancer Chemotherapy.
    Davis MK; Virani SA
    Can J Cardiol; 2016 Jul; 32(7):926-30. PubMed ID: 27245087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
    Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment and Management of Cardiotoxicity in Hematologic Malignancies.
    Bojan A; Torok-Vistai T; Parvu A
    Dis Markers; 2021; 2021():6616265. PubMed ID: 33613788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An update on the risk prediction and prevention of anticancer therapy-induced cardiotoxicity.
    Bhave M; Shah AN; Akhter N; Rosen ST
    Curr Opin Oncol; 2014 Nov; 26(6):590-9. PubMed ID: 25233068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of cardiac magnetic resonance imaging in the detection and monitoring of cardiotoxicity in patients with breast cancer after treatment: a comprehensive review.
    Jafari F; Safaei AM; Hosseini L; Asadian S; Kamangar TM; Zadehbagheri F; Rezaeian N
    Heart Fail Rev; 2021 May; 26(3):679-697. PubMed ID: 33029698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM).
    Totzeck M; Aide N; Bauersachs J; Bucerius J; Georgoulias P; Herrmann K; Hyafil F; Kunikowska J; Lubberink M; Nappi C; Rassaf T; Saraste A; Sciagra R; Slart RHJA; Verberne H; Rischpler C
    Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):792-812. PubMed ID: 36334105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology.
    Spallarossa P; Maurea N; Cadeddu C; Madonna R; Mele D; Monte I; Novo G; Pagliaro P; Pepe A; Tocchetti CG; Zito C; Mercuro G
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1(Suppl 1):S84-92. PubMed ID: 27183529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Newest echocardiographic techniques for the detection of cardiotoxicity and heart failure during chemotherapy.
    Sawaya H; Plana JC; Scherrer-Crosbie M
    Heart Fail Clin; 2011 Jul; 7(3):313-21. PubMed ID: 21749883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac Imaging Methods for Chemotherapy-related Cardiotoxicity Screening and Related Radiation Exposure: Current Practice and Trends.
    Kolla BC; Roy SS; Duval S; Weisdorf D; Valeti U; Blaes A
    Anticancer Res; 2017 May; 37(5):2445-2449. PubMed ID: 28476812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.